Raska et al. further demonstrated that both systemic and mucosal immunization with Candida Hsp90 could elicit increased levels of both serum and vaginal Hsp90-specific IgG and IgA antibodies, resulting in enhanced humoral response during experimental vaginal candidiasis [190]. The gene discussed is CD79A; the disease is vulvovaginal candidiasis.